Posts

Vol.6 No.4 – 2: Protective effect of omega-3 on Doxorubicin-induced hepatotoxicity in male albino rats

/0 Comments/in , , /by

By: 1Farozia I. Moussa, 1Horeya S. Abd El-Gawad, 1Salwa S. Mahmoud, 2Faiza A. Mahboub, and 1Saliha G.Abdelseyd

1Department of Zoology, Faculty of Science, Alexandria University, Egypt

2Department of Biology, Faculty of Applied Sciences, Umm Al-Qura University, Saudi Arabia

Abstract

Doxorubicin (DOX) is an antineoplastic anthracycline used to treat various forms of cancer. Although DOX is an effective chemotherapeutic agent, it has been documented to cause oxidative damage in several body organs. The present study aimed to investigate the protective effects of omega-3 against doxorubicin-induced hepatic toxicity in adult male rats. Animals were divided into four groups. The first group was orally administered with 0.5ml corn oil and served as a control group. The second group was treated with omega-3 fatty acid (400mg/kg b.w) daily for 30 days. The third group was injected intraperitoneally with a single dose of DOX (30mg/kg b.w). Animals in the fourth group were treated with omega-3 at the same dose level as those of group 2 followed by intraperitoneal injection of a single dose of DOX as in the third group. Injecting animals with DOX induces various histological changes in the liver. These changes include congestion and dilatation of blood vessels, leucocytic infiltration, cytoplasmic vacuolization, degenerated hepatocytes, and pyknotic nuclei. Moreover, DOX caused a significant elevation in serum ALT, AST, LDH, lipid profile, total bilirubin, total protein, albumin, and globulin after 4 weeks of treatment. It also caused an increase in malondialdehyde (MDA) and depletion of the antioxidant enzymes, catalase (CAT), superoxide dismutase (SOD), and reduced glutathione reduced (GSH). Treating animals with omega 3 fatty acids in combination with DOX led to an improvement in the histological and biochemical changes induced by DOX together with a significant decrease in the level of MDA and an increase in the activity of antioxidant enzymes. The results of the present work indicated that omega-3 fatty acid had a protective effect against liver damage induced by Doxorubicin and this is due to its antioxidant activities.

Protective-effect-of-omega-3-on-Doxorubicin-induced-hepatotoxicity-converted

Download PDF

Vol.1 No.5 -6 : Study of the effect of silver nanoparticles encapsulated by doxorubicin drug in the treatment of hepatocellular carcinoma.

/0 Comments/in , , /by

By : Rasha Said Shams El-Dine1, Samir Ali Abd El Kaream2

Abstract

Hepatocellular carcinoma (HCC) is the third deadliest and fifth most common cancer worldwide. Many drugs that have the potential to treat cancers have had limited success due to their lack of efficient and safe delivery mechanisms that allow the drug molecules to cross cell membranes. Electrical pulses-mediated drug delivery, known as electroporation, is gaining attention as a possible approach to enhance uptake of chemotherapy. The present work studied the effect of silver nanoparticles encapsulated by doxorubicin drug in the treatment of hepatocellular carcinoma. The study was conducted on 40 albino mice weighting 20-25 g of 8-10 weeks of age, and were divided into two major groups. Group A:10 mice were used as a control , group B: 40 mice have induced HCC by DABE this group were subdivided into three subgroups; sub groupB1 10 mice which were not received any treatment, and were kept at room environment and, sub group B2: 10 mice were injected i.p with a dose of 50 mg/kg body weight of doxorubicin only every day for 21days, sub group B3 :10 mice were injected i.p. with a dose of 50 mg/kg body weight of doxorubicin encapsulated by the silver nanoparticles every day for 21days.Parts of liver tissue and blood samples were collected from all from mice of each group for histopathological examination; the nanocapsules were of the size range 200 ± 20 nm and loaded with the positively charged anticancer drug doxorubicin with an efficiency of 89%. The loading of the drug into the capsule occurs by virtue of the pH-responsive property of the capsule wall, which is determined by the pKa of the polyelectrolytes. As the pH is varied, about 64% of the drug is released in acidic pH while 77% is released in neutral pH. Molecular detection of Alpha-fetoprotein (AFP) and Glypican-3 (gly3) mRNAs by RT-PCR before and after treatment by silver nanoparticles encapsulated doxorubicin drug were studied in mice with HCC. Silver nanoparticles encapsulated doxorubicin drug showed effective results for treatment of HCC compared to results obtained with doxorubicin drug resulting in reduced tumor growth, and induction of apoptosis in the treated cells by enhancing of delivering chemotherapy and anticancer drugs with enhanced efficacy and fewer adverse effects.

6. Study of the effect of silver nanoparticles encapsulated by doxorubicin drug in the treatment of hepatocellular carcinoma.
Download Issue